CANARY SPEECH, INC.

From the company

Canary Speech develops patented vocal biomarker technology that uses voice AI to screen for mood and disease states from short speech samples. Its Canary Ambient tool provides ambient listening for objective detection of cognitive and behavioral conditions, offering clinicians decision-support signals related to mood and cognitive status. The company holds twenty three issued patents and is HIPAA-compliant.